Target intelligence / Profile preview

Ring finger protein 31 (HOIP) (HOIP)

Target
HOIP
Molecular classification
Enzyme, E3 ubiquitin-protein ligase, RBR (RING-Between-RING) family E3 ligase
01

Overview

Ring finger protein 31 (RNF31), commonly known as HOIP, is the essential catalytic subunit of the Linear Ubiquitin Chain Assembly Complex (LUBAC). It is the only known E3 ubiquitin ligase capable of generating M1-linked (linear) ubiquitin chains, which act as critical scaffolds for the recruitment and activation of the IKK complex and subsequent NF-kappaB signaling (UniProt Q96EP0). Beyond its role in pro-survival signaling, HOIP is a key regulator of the cell death rheostat, preventing TNF-induced apoptosis and necroptosis by stabilizing the TNFR1-associated signaling complex (PubMed: 21455180). In the context of oncology, HOIP is frequently overexpressed or mutated in activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL), where it drives constitutive NF-kappaB activation and tumor cell survival (PubMed: 21455181). Therapeutic interest in HOIP focuses on the development of small-molecule inhibitors targeting its RING-Between-RING (RBR) catalytic domain to suppress pathological inflammation and sensitize resistant cancer cells to apoptosis-inducing therapies (PubMed: 32694140).

Other names
RNF31HOIL-1-interacting proteinZIBRAZinc finger protein binding to RNALUBAC catalytic subunit
02

Mechanism of action

Inhibition of the RBR (RING-Between-RING) catalytic domain to prevent the assembly of M1-linked linear ubiquitin chains, thereby blocking NF-kappaB activation and sensitizing cells to TNF-induced apoptosis.

03

Biological functions

Linear ubiquitination (M1-linked)NF-kappaB signaling pathway activationRegulation of apoptosisRegulation of necroptosisImmune response modulationTNF-alpha signaling transductionWnt signaling regulation
04

Disease associations

Activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL)Breast cancerColorectal cancerAutoinflammation and immune deficiency syndrome (AMDS)Rheumatoid arthritisSystemic lupus erythematosus
05

Safety considerations

Risk of systemic immunodeficiencyPotential for triggering autoinflammatory responsesImpairment of lymphoid organ developmentPotential hepatotoxicity based on knockout models
06

Interacting drugs

HOIPIN-1

4 more in the full profile.

07

Biomarkers

M1-linked ubiquitin chain levelsNF-kappaB p65 phosphorylation/nuclear translocationRNF31 mRNA expression levelsHOIP protein expression (IHC)CYLD expression levels

Beyond the preview

Go deeper on Ring finger protein 31 (HOIP) (HOIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ring finger protein 31 (HOIP) (HOIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call